Results 131 to 140 of about 2,510,208 (357)

Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study

British Journal of Clinical Pharmacology, EarlyView.
Aims To enhance understanding of betamethasone and its metabolites' pharmacokinetics in pregnancy, specifically early‐onset pre‐eclampsia, through a population pharmacokinetic model. Additionally, to investigate the placental metabolism and transfer of betamethasone and its main metabolites.
Sam Schoenmakers, Letao Li, Anna C. M. Kluivers, Michelle Broekhuizen, Madhavi S. Harhangi, A. H. Jan Danser, Irwin Reiss, Karel Allegaert, Sjoerd A. A. van den Berg, Bertrand D. van Zelst, Ron H. N. van Schaik, Philip L. J. DeKoninck, Emma Ronde, Sebastiaan D. T. Sassen, Sinno H. P. Simons, Birgit C. P. Koch   +15 more
wiley   +1 more source

Withdrawal syndrome [PDF]

Nature Medicine, 2004
openaire   +2 more sources

Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial

British Journal of Clinical Pharmacology, EarlyView.
Aims Patients with severe mental disorder and diabetes may be exposed to inappropriate polypharmacy increasing the risk of side effects and drug interactions. Although medication reviews may facilitate short‐term deprescribing, they are not known to affect clinical outcomes.
Johan Frederik Mebus Meyer Christensen, Signe Wegmann Düring, Gesche Jürgens   +2 more
wiley   +1 more source

Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents

British Journal of Clinical Pharmacology, EarlyView.
Aims We sought to characterize adverse events and deaths associated with the use of psychoactive substances in children and adolescents. Methods Two French Addictovigilance databases were analysed: spontaneous reports and deaths over the period 2016–2021, in subjects aged 10–<18 years. An unsupervised classification was implemented on consumption data (
Hélène Peyrière, Anne Batisse, Nathalie Fouilhé Sam‐Laï, Amélie Daveluy, Christine Fournier‐Choma, Sylvie Deheul, Cécile Chevalier, Clémence Lacroix, Valérie Gibaja, Aurélie Aquizerate, Stéphanie Pain, Emilie Jouanjus, Marie‐Christine Picot, Erika Nogue   +13 more
wiley   +1 more source

Effect of Morphine Withdrawal Syndrome on Cerebral Ischemia [PDF]

Iranian Journal of Basic Medical Sciences, 2011
Objective(s)Opioid abuse is still remained a major mental health problem, a criminal legal issue and may cause ischemic brain changes including stroke and brain edema.
Mohammad Allahtavakoli, Ruhollah Moloudi, Mohammad Ebrahim Rezvani, , Ali Shamsizadeh   +3 more
doaj  

P01.56 Gamma-hydroxy buthyric acid (alcover) in the treatment of alcohol withdrawal syndrome [PDF]

, 2000
Lajos Kovács, Gábor L. Kovaćs
openalex   +1 more source

Withdrawal Syndromes

Journal of the Royal College of Physicians of London, 1987
I A, Liappas, F A, Jenner, B, Vicente
openaire   +2 more sources

Preventive Effect of Central Administration of Venlafaxine on Morphine Physical Dependence, Nociception, and Blood Cortisol Level in Rat

International Journal of Preventive Medicine, 2014
Background: Chronic abuse of opiates induces dependency, but the neurobiological mechanisms of this event remain unclear. The aim of this study was to evaluate the effects of intracerebroventricular of venlafaxine on the morphine dependence and pain ...
Majid Motaghinejad, Andia Ebrahimzadeh, Behnaz Shabab   +2 more
doaj  

Awareness of Surgical and Medical Intensive Care Nurses’ about Alcohol Withdrawal Syndrome and Care Practices

Addicta: The Turkish Journal on Addictions
Alcohol withdrawal syndrome is a significant global health concern affecting individuals with alcohol use disorder, particularly in hospital settings like intensive care units.
Nurgül Arpag, Hamdiye Banu Katran, Ali Haspolat, Ali Şefik Köprülü   +3 more
doaj   +1 more source

The Relevance of Board Diversity Features in a Weak Institutional Business Environment

Business Strategy and the Environment, Volume 34, Issue 5, Page 5299-5316, July 2025.
ABSTRACT The board diversity literature continues to advance a simplistic but empirically unsubstantiated rhetoric of the board diversity accountability, economic benefits and its relationship with other firm characteristics. Yet, less is understood about which board diversity features actually matter for business decision‐making, especially in weak ...
Folajimi Ashiru, Emmanuel Adegbite, Subhan Ullah, Amir Michael, Neil Pyper   +4 more
wiley   +1 more source